Attendees gathered Thursday evening for the inaugural SABCS® Celebration. View photos from the event, which featured live music, dancing, and chances to catch up with colleagues.

Otto Metzger, MD; E. Shelley Hwang, MD, MPH; and Ann H. Partridge, MD, MPH, were among 10 experts reporting results Thursday during the second General Session of the 2024 San Antonio Breast Cancer Symposium®.

2024 William L. McGuire Memorial Lecture Award recipient Laura J. van ‘t Veer, PhD, reviewed career milestones, including the invention of the 70-gene MammaPrint lab test, during her address on Wednesday.

Plan your Friday schedule and don’t miss notable items on the program, including the third General Session, a session for pathologists about IHC testing, and a debate on universal germline genetic testing.

The Year in Review and View from the Trenches sessions on Friday afternoon and evening will wrap up this year’s Symposium and set the stage for discussions to come.

Olivera (Olja) J. Finn, PhD, will explore the progress and challenges related to therapeutic cancer vaccines during a Friday afternoon session on breast cancer risk reduction and early detection.

Allison Kurian, MD, MSc, and Raymond Kim, MD, PhD, will share opposing perspectives on germline testing for genetic variants associated with breast cancer during a Friday afternoon debate.

Komal L. Jhaveri, MD; Matteo Lambertini, MD, PhD; and Judy E. Garber, MD, MPH, were among the experts presenting findings from six studies Wednesday during the first General Session of the 2024 San Antonio Breast Cancer Symposium®.

Nobel Prize winner William G. Kaelin, Jr., MD, presented the 2024 SABCS® keynote address on Wednesday and spoke about emerging and reemerging principles for controlling cancer with drugs.

Watch this special video that was presented before the first General Session on Wednesday, highlighting progress in breast cancer research and treatment, and acknowledging the important contributions of the patient advocacy community.